Skip to main content
Vefa İlaç San. ve Tic. A.Ş.

Latest Updates

News & Announcements

Follow Vefa İlaç corporate developments, events and announcements.

LinkedIn — CPHI Milan 2026’da standımızda değerli misafirlerimizi ağırlama fırsatı bulduk.

We had the pleasure of welcoming distinguished guests to our stand at CPHI Milan 2026.

We had the pleasure of welcoming distinguished guests to our stand at CPHI Milan 2026.

Read More
LinkedIn — Eylül | Ağrı Farkındalık Ayı

September | Pain Awareness Month

Every September, awareness activities are held worldwide to draw attention to the impact of pain on individuals and society. The International Association for the Study of Pain designated “Neuropathic Pain” as the theme for 2026.

Read More
LinkedIn — 13 Eylül - Uluslararası Primer Biliyer Kolanjit Farkındalık Günü

September 13 - International Primary Biliary Cholangitis Awareness Day

Every year on the second Sunday of September, patient organizations observe International PBC Awareness Day to highlight the challenges people with Primary Biliary Cholangitis face during diagnosis and in daily life.

Read More
As Vefa İlaç & VeNatura, we attended the 2nd Congress of the Federation of Women’s Health Associations on 22–26 April 2026.
Event

As Vefa İlaç & VeNatura, we attended the 2nd Congress of the Federation of Women’s Health Associations on 22–26 April 2026.

We attended the 2nd Congress of the Federation of Women’s Health Associations.

Read More
We ranked 21st among the top 50 companies by number of trademarks obtained under Turkishtime R&D 250.
R&D

We ranked 21st among the top 50 companies by number of trademarks obtained under Turkishtime R&D 250.

In the Turkishtime R&D 250 research, we ranked 21st among the top 50 companies by trademark registrations — an important marker of our R&D and innovation investments.

Read More
Our poster prepared by our R&D Center won an award at the 10th International Pharmaceutical Chemistry Congress.
R&D

Our poster prepared by our R&D Center won an award at the 10th International Pharmaceutical Chemistry Congress.

At the 10th International Pharmaceutical Chemistry Congress, the poster presented by our R&D Center was recognised by the scientific jury.

Read More
We ranked 2nd in the 'Pharmaceutical Company with the Most Trademarks in R&D Center' category at the 10th National Pharmaceutical Chemistry Congress organized by the Chemists' Association.
R&D

We ranked 2nd in the 'Pharmaceutical Company with the Most Trademarks in R&D Center' category at the 10th National Pharmaceutical Chemistry Congress organized by the Chemists' Association.

At the 10th National Pharmaceutical Chemistry Congress organized by the Chemists' Association, we were recognised in the 'Pharmaceutical Company with the Most Trademarks in R&D Center' category.

Read More
8th International Congress on Pharmaceutical Chemistry, Active Ingredient Design, Synthesis, Production and Standardization.
Event

8th International Congress on Pharmaceutical Chemistry, Active Ingredient Design, Synthesis, Production and Standardization.

We participated in the 8th International Pharmaceutical Chemistry Congress with presentations on active ingredient design, synthesis, and production standardization.

Read More
Whitefest 2020
Corporate

Whitefest 2020

At the Whitefest 2020 event, the Vefa İlaç team came together for a corporate gathering focused on motivation and collaboration.

Read More
Azerbaijan Baku Vefa İlaç D-Colerol (D-Colefor) Launch
Launch

Azerbaijan Baku Vefa İlaç D-Colerol (D-Colefor) Launch

At our launch event in Baku, Azerbaijan, we introduced our D-Colerol (D-Colefor) product to healthcare professionals.

Read More